Immunotherapy for non-Hodgkinʼs lymphoma
- 1 September 1996
- journal article
- review article
- Published by Wolters Kluwer Health in Current Opinion in Oncology
- Vol. 8 (5) , 353-359
- https://doi.org/10.1097/00001622-199609000-00003
Abstract
Humanized monoclonal anti-CD20 has impressive activity and radioimmunoconjugates. Targeting the same molecule has led to prolonged remissions in both moderate and myeloablative doses. Idiotype-based vaccination has produced an apparent prolongation in disease-free and overall survival in selected patients with follicular lymphoma. Adoptive cellular therapy is active in the setting of Epstein-Barr virus-induced lymphoma after allogenic bone marrow transplantation. Improvements in each of these developments are readily in sight.Keywords
This publication has 0 references indexed in Scilit: